Presentation TCT 2016

Quality-of-Life Measures as Valid Clinical Surrogates and Primary Endpoints in Randomized Trials: Why the Resistance?

Presenter: John A. Spertus

October 30, 2016

REGISTER for free or LOG IN to view this content

Quality-of-Life Measures as Valid Clinical Surrogates and Primary Endpoints in Randomized Trials: Why the Resistance?

Presentation

TCT 2016

Quality

Up Next

Presentation TCT 2016

Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation

Presenter: Vivek Y. Reddy

October 30, 2016

More slides +

Presentation TCT 2016

Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials

Presenter: Susheel K. Kodali

October 30, 2016

Presentation TCT 2016

Brazil Presents a Case: Complex Access in TAVI the Transcaval Approach

Presenter: Dimytri Alexandre Siqueira

October 30, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.